Verastem (VSTM) Cash from Investing Activities (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Verastem | 425.60 Mn | 243.93 Mn | 15.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,090.71% |
| Jun 30, 2024 | -6.41% |
| Mar 31, 2024 | 149.11% |
| Dec 31, 2023 | 117.75% |
| Sep 30, 2023 | -600.56% |
| Jun 30, 2023 | 1,841.29% |
| Mar 31, 2023 | -106.17% |
| Dec 31, 2022 | 180.29% |
| Sep 30, 2022 | -84.11% |
| Jun 30, 2022 | 51.83% |
| Mar 31, 2022 | 29,087.88% |
| Dec 31, 2021 | -99.34% |
| Sep 30, 2021 | 317.89% |
| Jun 30, 2021 | 119.34% |
| Mar 31, 2021 | 84.41% |
| Dec 31, 2020 | -1,322,900.00% |
| Sep 30, 2020 | 77.78% |
| Jun 30, 2020 | -100.08% |
| Mar 31, 2020 | 27.56% |
| Dec 31, 2019 | 42.81% |
| Sep 30, 2019 | -62.19% |
| Jun 30, 2019 | 12,718.18% |
| Mar 31, 2019 | 100.29% |
| Dec 31, 2018 | -719.19% |
| Sep 30, 2018 | -2,820.57% |
| Jun 30, 2018 | -111.95% |
| Mar 31, 2018 | -1.64% |
| Dec 31, 2017 | -78.86% |
| Sep 30, 2017 | 52.07% |
| Jun 30, 2017 | 242.36% |
| Mar 31, 2017 | 315.42% |
| Dec 31, 2016 | -73.56% |
| Sep 30, 2016 | -88.01% |
| Jun 30, 2016 | 2,717.75% |
| Mar 31, 2016 | -92.73% |
| Dec 31, 2015 | 500.71% |
| Sep 30, 2015 | -142.40% |
| Jun 30, 2015 | 118.87% |
| Mar 31, 2015 | -451.62% |
| Dec 31, 2014 | 76.90% |
| Sep 30, 2014 | -57.48% |
| Jun 30, 2014 | 335.21% |
| Mar 31, 2014 | 47.49% |
| Dec 31, 2013 | 106.43% |
| Sep 30, 2013 | -441.99% |
| Jun 30, 2013 | -131.73% |
| Mar 31, 2013 | 416.06% |
| Dec 31, 2012 | 132.01% |
| Sep 30, 2012 | 145.13% |
| Jun 30, 2012 | 90.30% |
| Mar 31, 2012 | -34.30% |
| Dec 31, 2011 | -9,624.12% |
| Sep 30, 2011 | 21.66% |